News brief
Researchers at Baylor College of Medicine have found a promising way to address Alzheimer's disease by utilizing the brain's support cells, astrocytes. By boosting a protein called Sox9, they enhanced these cells' ability to clear amyloid plaques in mouse models. This not only reduced plaque buildup but also preserved cognitive function in mice with memory issues, pointing to a new direction for future treatments.
Key points
- Astrocytes can be activated to clear amyloid plaques.
- Increasing Sox9 improves cognitive function in mice.
- The study opens new avenues for Alzheimer's treatments.
Astrocytes and Alzheimer's
Astrocytes, the star-shaped cells in our brains, are vital for maintaining brain health. In Alzheimer's, these support cells can be guided to remove harmful amyloid plaques, a hallmark of the disease. Researchers have zeroed in on the protein Sox9, which influences astrocyte activity as we age, to see if it could help in the fight against Alzheimer's.
The Role of Sox9
In their study, scientists manipulated the Sox9 gene in Alzheimer's mouse models. By increasing Sox9 levels, they saw that astrocytes became more active, leading to better clearance of amyloid plaques. Mice with higher Sox9 levels not only had fewer plaques but also showed improved cognitive function, highlighting the protein's potential to slow cognitive decline.
Why it matters
These findings suggest that enhancing the brain's natural support system could be a promising strategy for treating neurodegenerative diseases like Alzheimer's. Understanding Sox9's role in the human brain is the next step, but this study paves the way for therapies that use astrocytes as a natural defense. This approach offers a fresh alternative to treatments that mainly target neurons.
Discover more from Neurospan
Subscribe to get the latest posts sent to your email.
